Hülya Yanal

Hülya Yanal

Auto-generated profile, based on publicly available information

Hülya Yanal

Department of Anesthesiology and Reanimation, İlhan Özdemir Public Hospital, Giresun, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Thoracic Research and Practice
Verified
Journal Article
Open access
SGSinem Gungor
Sinem Gungor
ÖEÖzlem Ediboğlu
Özlem Ediboğlu
ÖMÖzlem Yazıcıoğlu Moçin
Özlem Yazıcıoğlu Moçin
NANalan Adıgüzel
Nalan Adıgüzel
ETEylem Tunçay
Eylem Tunçay
FTFiliz Tüzüner
Filiz Tüzüner
COVID-19,intensive care,intensive care unit,pandemic,follow-up

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
TATuna Albayrak
Tuna Albayrak
HYHülya Yanal
Hülya Yanal
DSDemet Sengul
Demet Sengul
ISIlker Sengul
Ilker Sengul
MAMehmet Albayrak
Mehmet Albayrak
ECEsma Cinar
Esma Cinar
The objective of this study was to compare the clinical outcomes of percutaneous dilatational tracheostomy in COVID-19 and non-COVID-19 patients. A total of 48 patients who underwent percutaneous dilatational tracheostomy, with 24 COVID-19 patients (Group C) and 24 non-COVID-19 patients (Group N), were included in the study. Patients’ demographic features including age and gender, time to intubation, duration of intubation, Acute Physiology and Chronic Health Evaluation scores, comorbidities, duration of opening tracheostomy, complications, duration of mechanical ventilation, length of stay in the intensive care units, and mortality were recorded and compared between the groups. There was no statistically significant difference between the groups regarding age and gender (p=0.558 and p=0.110, respectively). Time to intubation was significantly more prolonged, and intubation follow-up duration was significantly shorter in Group C compared to Group N (p=0.034 and p=0.002, respectively). The Acute Physiology and Chronic Health Evaluation score was statistically significantly higher in Group N compared with Group C (p=0.012). The most common comorbidity was hypertension in 29 (60.4%) patients, followed by cerebrovascular disease in 19 (39.6%) patients. There was no statistically significant difference between the groups regarding mortality (p=0.212). This study suggests that percutaneous dilatational tracheostomy can be performed safely in COVID-19 and non-COVID-19 patients. However, COVID-19 patients may have a longer time to intubation and shorter intubation follow-up duration than non-COVID-19 patients. The study also found a higher incidence of complications in COVID-19 patients undergoing percutaneous dilatational tracheostomy. These results emphasize the importance of careful patient selection, meticulous technique, and close postoperative monitoring in patients undergoing percutaneous dilatational tracheostomy, particularly in those with COVID-19.